All-cause and liver-related mortality among people who inject drugs with chronic hepatitis C virus infection in Oslo, Norway

Key Points

• To investigate the causes of mortality among individuals who inject drugs and have chronic hepatitis C virus infection.
• Analyzed mortality data of individuals with chronic HCV infection in Oslo.
• Categorized deaths into liver-related and drug-related causes.
• Examined the impact of untreated HCV and liver cirrhosis on overall mortality.
• Liver-related mortality was low among individuals with HCV cirrhosis.
• Overall mortality was higher in those with untreated HCV infection.
• Notably, drug-related deaths were a significant contributor to all-cause mortality.